Aseptika Launches PUFFClicker3 Universal Inhaler Dose Counter

Aseptika launched its PUFFClicker3, a universal smart inhaler dose tracker that is compatible with pressurized metered dose inhalers (pMDI) and dry powder inhalers (DPI).  
 
The PUFFClicker3 was developed to improve inhaler adherence, for patients of all ages and respiratory conditions that require inhalers for treatments. It supports 101 SNOMED-coded inhalers and offers built-in graphical instructions on how each inhaler supports it, making the switch to a new type of inhaler simple. 
 
The PUFFClicker3 universal inhaler dose counter includes:

• Compatibility with 101 SNOMED-coded pressurized metered dose (pMDI) and dry powder inhalers (DPI), offering a Universal Inhaler Dose Counter.

• User-friendly design with its touch screen for ease of operation.

• Incorporation of simple animated graphics and sounds, providing guidance on how to use different types of pMDI and DPI inhalers, as well as the PUFFClicker3 device itself. 

• Inclusive design with support for 16 languages (Arabic, Bengali, Czech, English, Gujarati, Hindi, Italian, Latvian, Lithuanian, Polish, Punjabi, Romanian, Russian, Spanish, Ukrainian, and Urdu), aimed at addressing health inequities stemming from language barriers. This aligns with the NHS Core20PLUS initiative, which targets patients who can find it sometimes difficult to access healthcare.

• Eliminating the need for a smartphone to transmit inhaler medication adherence data to the Cloud, enabling direct communication with parents, carers, and healthcare staff. Additionally, the device stores data locally, providing patients with feedback on doses taken, upcoming dosage schedules, and remaining doses in the inhaler. 

The PUFFClicker3 has received initial backing from an Innovate UK Smart Award.
 
Aseptika has started a Patient and Public Involvement and Engagement (PPIE) initiative to enhance the health and well-being of young people. PUFFClicker3 is currently being tested on children and young people aged 6-18 with poorly controlled asthma.
 
The initiative is backed by funding from SBRI Healthcare Phase I, an Accelerated Access Collaborative initiative. As part of the PPIE initiative, Aseptika is engaging with Asthma Nurses, GPs, and Pharmacists to explore future pathways for introducing inhaler adherence through a straightforward 30-day implementation process. The goal is to prompt behavior changes by providing a PUFFClicker3 device alongside inhalers, enabling data transmission for healthcare review by healthcare professionals during asthma assessments.
 
Aseptika will exhibit the PUFFClicker3 at stand C37 at the Med-Tech Innovation Expo at the NEC on June 5-6, 2024.